Hydatidiform Mole Presents As Pregnancy in a 48-Year-Old Perimenopausal Female: A Case Study.
benign
gestational trophoblastic disease
human chorionic gonadotropin
hydatidiform mole
metastatic
perimenopausal
pregnancy
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
accepted:
16
02
2022
entrez:
28
2
2022
pubmed:
1
3
2022
medline:
1
3
2022
Statut:
epublish
Résumé
Pregnancy should be suspected whenever a woman in her childbearing years misses a menstrual period. Clinical suspicion is increased if she also reports any sexual activity while not using contraception or is inconsistent in her use of contraception. Laboratory findings that aid in the diagnosis of pregnancy include the detection of human chorionic gonadotropin (hCG) in blood or urine. Hydatidiform mole (HM) is part of a group of diseases classified under gestational trophoblastic disease (GTD), which originate in the placenta and have the potential to locally invade the uterus and metastasize. Although molar pregnancies are designated as benign, they have the potential to develop into a malignancy. In this case study, we present a 48-year-old peri-menopausal female patient, with a 1+ year history of irregular menses, who presented to the clinic with signs and symptoms of pregnancy, unprotected sexual activity, and a positive at-home pregnancy test. Upon further workup of the patient, it was diagnosed that the patient had a hydatidiform molar pregnancy. It is interesting to note that benign gestational trophoblastic diseases generally occur in younger women, of "reproductive age" (generally in their twenties to early thirties), and is extremely rare in peri- and post-menopausal women.
Identifiants
pubmed: 35223328
doi: 10.7759/cureus.22291
pmc: PMC8858793
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e22291Informations de copyright
Copyright © 2022, Ftiha et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Am J Obstet Gynecol. 1976 Nov 15;126(6):678-81
pubmed: 984142
Br J Obstet Gynaecol. 1986 Jun;93(6):582-5
pubmed: 3755352
Clin Chem. 2009 Aug;55(8):1484-91
pubmed: 19541864
Eur J Obstet Gynecol Reprod Biol. 1997 Jan;71(1):67-71
pubmed: 9031962
Lancet. 2010 Aug 28;376(9742):717-29
pubmed: 20673583
Paediatr Perinat Epidemiol. 1994 Jan;8(1):62-78
pubmed: 8153019
Fertil Steril. 2009 Feb;91(2):522-7
pubmed: 18433748
N Engl J Med. 1999 Jun 10;340(23):1796-9
pubmed: 10362823
Hum Reprod. 2003 Sep;18(9):1944-7
pubmed: 12923154
N Engl J Med. 1996 Dec 5;335(23):1740-8
pubmed: 8929267
Obstet Gynecol. 1995 Nov;86(5):775-9
pubmed: 7566847
Fertil Steril. 1982 Jun;37(6):773-8
pubmed: 7115557
J Reprod Med. 1998 Jan;43(1):21-7
pubmed: 9475145
Arch Pathol Lab Med. 2004 Sep;128(9):1039-42
pubmed: 15338558
J Reprod Fertil. 1991 Jul;92(2):555-65
pubmed: 1886109
Transl Pediatr. 2015 Apr;4(2):181-8
pubmed: 26835372